Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 6Squamous Cell Carcinoma of Head and Neck 3Sarcoma 2Mouth Neoplasms 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Carcinoma 2Stomatitis 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Prostate Adenocarcinoma 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Melanoma 1Malignant Liver Neoplasm 1Lung Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Chondrosarcoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma 1

Interventions

Gemcitabine 7Albumin-Bound Paclitaxel 5Taxes 4Fluorouracil 4dehydroftorafur 3Radiotherapy 3Oxaliplatin 3Radiotherapy, Intensity-Modulated 2Losartan 2Leucovorin 2Irinotecan 2130-nm albumin-bound paclitaxel 2irinotecan sucrosofate 1indusatumab 1X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1S 1 (combination) 1Radiotherapy, Image-Guided 1Radiation 1Pancreatectomy 1Folfox protocol 1Erlotinib Hydrochloride 1Cetuximab 1Capecitabine 1Anesthesia, General 1Anesthesia 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pancreatic Adenocarcinoma × Radiotherapy, Image-Guided × Clear all
NCT02427841 2023-09-06

Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

OHSU Knight Cancer Institute

Phase 2 Completed
20 enrolled 17 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡